低风险住院患者入住ICU的特征与结局:多中心队列研究
该历史性队列研究利用渥太华医院2011年1月至2016年12月的前瞻性ICU注册数据,纳入18岁及以上全部ICU患者,用入院时医院患者1年死亡风险评分(Hospital-patient 1-year Mortality Risk at admission score)划分低风险。17,173例ICU患者中3,445例(20.1%)入院时属低风险;低风险组较非低风险组更年轻(48.7 vs 67.5岁;p<0.001)、多器官功能障碍评分更低(2.37 vs 4.14;p<0.001),住院死亡率显著更低(4.1% vs 25.4%;p<0.001)。低风险患者中,多因素logistic回归显示死亡与年龄较大(每1岁OR 1.02;95%CI 1.00-1.03)、多器官功能障碍评分(每1分OR 1.42;95%CI 1.31-1.54)、液体管理不良事件(OR 2.84;95%CI 1.29-6.25)、院内感染(OR 1.60;95%CI 1.02-2.51)和机械通气(OR 1.98;95%CI 1.20-3.26)独立相关。提示对入院时低风险的患者入住ICU后仍需重视上述预后因素。
要点
- 17,173例ICU患者中3,445例(20.1%)入院时被评为低风险,其住院死亡率为4.1%,非低风险组为25.4%(p<0.001)。
- 低风险患者死亡与多器官功能障碍评分独立相关(每1分OR 1.42;95%CI 1.31-1.54)。
- 液体管理不良事件与低风险患者死亡独立相关(OR 2.84;95%CI 1.29-6.25)。
- 院内感染(OR 1.60;95%CI 1.02-2.51)和机械通气(OR 1.98;95%CI 1.20-3.26)也是低风险患者死亡的独立相关因素。
- 年龄每增加1岁与低风险患者死亡风险轻度升高独立相关(OR 1.02;95%CI 1.00-1.03)。
适用人群与场景
- 2011年1月至2016年12月渥太华医院所有18岁及以上入住ICU的患者,前瞻性维护的ICU注册数据。
诊断标准与关键阈值
- 低风险定义:入院时医院患者1年死亡风险评分(Hospital-patient 1-year Mortality Risk at admission score)低风险分类,该评分已验证用于预测1年死亡率。
研究设计与关键结果
- 研究类型:历史性队列研究,使用前瞻性维护的ICU注册数据,纳入18岁及以上ICU患者17,173例;低风险3,445例(20.1%)。
- 低风险组 vs 非低风险组:年龄48.7 vs 67.5岁(p<0.001);多器官功能障碍评分2.37 vs 4.14(p<0.001);住院死亡率4.1% vs 25.4%(p<0.001)。
- 低风险患者多因素logistic回归:年龄每1岁OR 1.02(95%CI 1.00-1.03);多器官功能障碍评分每1分OR 1.42(95%CI 1.31-1.54);液体管理不良事件OR 2.84(95%CI 1.29-6.25);院内感染OR 1.60(95%CI 1.02-2.51);机械通气OR 1.98(95%CI 1.20-3.26)。
证据类型、等级与局限
- 证据类型:历史性队列研究;局限:原文未报告局限性。
对床旁实践的改变
- 对入院时评为低风险但后续入住ICU的患者,死亡率仍达4.1%,不能仅凭入院低风险评分低估ICU期间死亡风险。
- 作者认为液体管理不良事件、院内感染、多器官功能障碍和机械通气是低风险患者的重要预后因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Prognostication following ICU admission can often be determined based on known risk factors, including demographics and illness severity; however, little is known about outcomes of patients deemed to be "low-risk" at the time of hospital admission who subsequently are admitted to the ICU.
OBJECTIVES: The objectives of this study were to determine the characteristics, outcomes, and costs for patients requiring ICU admission despite having lower predicted mortality when they were admitted to the hospital.
DESIGN SETTING AND PARTICIPANTS: In this historical cohort study, we used a prospectively maintained ICU registry that included all ICU admissions to The Ottawa Hospital for patients 18 years or older from January 2011 to December 2016. We classified patients as low-risk using the Hospital-patient 1-year Mortality Risk at admission score, a hospital admission score validated to predict 1-year mortality.
MAIN OUTCOMES AND MEASURES: The primary outcome was inhospital mortality. Secondary outcomes included adverse events, resource utilization, and costs.
RESULTS: Of the 17,173 total ICU patients, 3,445 (20.1%) were classified as low-risk at hospital admission. Low-risk patients were younger (48.7 vs 67.5 yr; p < 0.001) and had a lower Multiple Organ Dysfunction Score (2.37 vs 4.14; p < 0.001). Mortality for low-risk patients was significantly lower than for non-low-risk patients (4.1% vs 25.4%; p < 0.001). For low-risk patients, multivariable logistic regression showed mortality was independently associated with older age (odds ratio, 1.02 per 1 yr; 95% CI, 1.00-1.03 per 1 yr), Multiple Organ Dysfunction Score (odds ratio, 1.42 per 1 point; 95% CI, 1.31-1.54 per 1 point), fluid management adverse events (odds ratio, 2.84; 95% CI, 1.29-6.25), hospital-acquired infections (odds ratio, 1.60; 95% CI, 1.02-2.51), and mechanical ventilation (odds ratio, 1.98; 95% CI, 1.20-3.26).
CONCLUSIONS AND RELEVANCE: Despite their robust premorbid status, low-risk patients admitted to the ICU had significant inhospital mortality. Fluid management adverse events, hospital-associated infections, multiple organ dysfunction, and mechanical ventilation are important prognostic factors for low-risk patients.
参考来源
- Prager RT, Pratte MT, Thompson LH, et al. Characteristics and Outcomes for Low-Risk Hospital Admissions Admitted to the ICU: A Multisite Cohort Study. Crit Care Explor. 2021. PMID: 34909699. doi:10.1097/CCE.0000000000000596
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。